Psychotherapeutic Drugs

The advancements of psychotherapeutic drugs has enabled management of mental illness and other neurological problems in the general population, without requiring hospitalization. The success of these drugs in controlling symptoms has led to their widespread use in the vulnerable population of pregnant women as well, where the potential embryotoxicity of the drugs has to be weighed against the potential problems of the maternal neurological state. A thorough discussion of animal research and human clinical studies is used to determine the risk associated with the use of each drug category. The direction of future research using psychotherapeutic drugs should more closely parallel the methodology developed in the animal laboratories, especially since these models have already been used extremely successfully in specific instances in the investigation of neurotoxic agents.

  • Global Psychotherapeutic Drugs
  • Cannabis and Cannabinoids
  • Psychoactive Drugs
  • Placebo Medications
  • Current Trends in Psychotherapeutic Drugs
  • Effects of Psychotherapeutic Drugs and Mental Health
  • Therapeutic Drugs and Myths

Related Conference of Psychotherapeutic Drugs

September 22-23, 2025

6th Annual Congress on Psychiatry

Paris, France
October 27-28, 2025

39th International Conference on Psychiatry and Mental Health

Amsterdam, Netherlands
November 10-11, 2025

International Congress on Cognitive Psychotherapy

Vancouver, Canada
November 10-11, 2025

5th Annual Psychiatrists and Psychologists Meet

Vancouver, Canada
November 24-25, 2025

5thAnnual Congress on Mental Health & Psychiatry

Barcelona, Spain
February 16-16, 2026

43rd Global Psychiatry and Mental Health Conference

Paris, France
February 16-17, 2026

6th Annual Congress on Mental Health

Paris, France
April 20-21, 2026

33rd World Psychiatrists and Psychologists Meet

Rome, Italy
May 27-28, 2026

8th European Autism Congress

Paris, France

Psychotherapeutic Drugs Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in